- ►worldsign.in [PDF] SL Bowker, SR Majumdar, P Veugelers, JA … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—We identified 10,309 new users of metformin or sulfonylureas with an average
follow-up of 5.4 ± 1.9 years (means ± SD). The mean age for the cohort was 63.4 ± 13.3
years, and 55% were men. Cancer mortality over follow-up was 4.9% (162 of 3,340) for ... Cited by 105 - Related articles - BL Direct - All 8 versions
AB King, G Wolfe, S Healy - Diabetes care, 2006 - Am Diabetes Assoc C ontrolled clinical trials have demon- strated the effectiveness of exenatide in reducing glucose
and weight (1– 4). We herein report our initial clinical experience. Clinic charts of the first 200
patients consecutivelytreatedwereretrospectively analyzed.Ofthesepatients,22%werelost ... Cited by 7 - Related articles - BL Direct - All 5 versions
LR Ranganath - British Medical Journal, 2008 - jcp.bmj.com Incretins such as glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like
peptide-1 (GLP-1) are intestinal postprandial hormones that stimulate insulin release from the
pancreas as long as circulating glucose concentrations are raised. In addition to their ... Cited by 7 - Related articles - BL Direct - All 4 versions
LR Ranganath - Clinical Chemistry and Laboratory Medicine, 2007 - reference-global.com Incretins such as glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide
1 (GLP-1) are intestinal hormones that are released in response to ingestion of nutrients, especially
carbohydrate. They have a number of important biological effects, which include release ... Cited by 6 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org AC Feldstein, GA Nichols, DH Smith, VJ Stevens, K … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—The weight-trajectory groups were defined as higher stable weight (n = 418;
16.2%), lower stable weight (n = 1,542; 59.9%), weight gain (n = 300; 11.7%), and weight loss
(n = 314; 12.2%). The latter had a mean weight loss of 10.7 kg (−9.8%; P < 0.001) by 18 ... Cited by 4 - Related articles - All 6 versions
A Tuthill, MJ McKenna, D O'Shea, TJ … - Diabetes, Obesity and …, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 2 - Related articles - All 2 versions
- ►insulinjournal.com [PDF] JA Duane, W Conway - Insulin, 2008 - Elsevier Methods: The clinical setting was a safety-net, rural community health center for the uninsured
and underinsured population in Hardin County, Tennessee. The patients were sick adults with
significant, often disabling disease, typically on treatments that were ineffective or ... Cited by 1 - Related articles - All 2 versions
O Cohen, C Norymberg, E Neumann, H Dekel - Diabetes Research and Clinical …, 2008 - Elsevier The two groups did no differ significantly in the duration of diabetes, age of onset and admission
HbA1c. The mean weight at admission was 78.9 ± 15.1 and 76.7 ± 15.0 kg (ns) respectively.
No significant weight changes were noted on initiation of oral treatment and at final visit. ... Cited by 1 - Related articles - All 15 versions
- ►diabetesjournals.org [PDF] WI Hussein, SS Reddy - Diabetes care, 2006 - Am Diabetes Assoc C ontrolled clinical trials have demon- strated the effectiveness of exenatide in reducing glucose
and weight (1– 4). We herein report our initial clinical experience. Clinic charts of the first 200
patients consecutivelytreatedwereretrospectively analyzed.Ofthesepatients,22%werelost ... Cited by 1 - Related articles - BL Direct - All 5 versions
FL Greenway, WT Cefalu - Type 2 Diabetes Mellitus: An Evidence-Based …, 2008 - Springer Summary The prevalence of obesity began rising about 1980, and one third of the US population
is now obese. The medical risks of obesity are linked to insulin resistance, and diabetes prevalence
follows that of obesity by a decade. This chapter approaches the treatment of obesity in ... Related articles - All 2 versions
